Both modalities affect blood flow, and their interaction requires consideration to optimize peptide delivery while maximizing anti-inflammatory benefits
Structures, representative synthetic procedures, in vitro validation of receptor activity and in vivo validation of weight-lowering efficacy in DIO mice for all peptide drugs have been published previously 30,31
What they did: Multiple preclinical models (mice, rats) evaluated the combination AOD-9604 + GLP-1 agonist (Semaglutide or Liraglutide)
Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, et al
We offer a comprehensive range of neuromodulators, including BOTOX, Dysport, Xeomin, and Letybo, to tailor your treatment for optimal results